Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorErpolat, O. P.
dc.contributor.authorAlco, G.
dc.contributor.authorCaglar, H. B.
dc.contributor.authorIgdem, S.
dc.contributor.authorSaran, A.
dc.contributor.authorDagoglu, N.
dc.contributor.authorAslay, I.
dc.contributor.authorOzsaran, Z.
dc.contributor.authorDemirci, S.
dc.contributor.authorKeven, E.
dc.contributor.authorGuney, Y.
dc.contributor.authorAkmansu, M.
dc.contributor.authorKilic, D.
dc.contributor.authorBayman, E.
dc.contributor.authorEtiz, D.
dc.contributor.authorMandel, N. M.
dc.date.accessioned2025-10-16T15:33:31Z
dc.date.issued2014
dc.identifier.otherWOS:000341554300015
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9258
dc.publisherI R O G CANADA, INC
dc.sourceEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
dc.subjectHematologic toxicity
dc.subjectCervical cancer
dc.subjectRadiotherapy
dc.subjectChemotherapy
dc.titleComparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS